Neurizon Therapeutics (NUZ.AX) traded up 3.8 % during a 24 hours period ending at 12:12 AM Central Europe on Tuesday 27th. One Neurizon Therapeutics stock can currently be bought for about AUD 0.09 on popular exchanges. Current supply of Neurizon Therapeutics stocks is 791.7 mn. Neurizon Therapeutics has a current market capitalization of AUD 64.9 mn and approximately AUD 26.7 k worth of Neurizon Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Neurizon Therapeutics has traded 6.49 % up. Simple moving average of last 200 days is at AUD 0.08. The highest price of past 52 weeks was recorded at AUD 0.12 on 12/11/2025. 52 weeks low was at AUD 0.05 on 09/02/2026.
Here is how related stocks have performed in the past 24 hours:
Lark Distilling (LRK.AX) traded down -1.41 % and now trades at AUD 0.7. Current market capitalisation for Lark Distilling is AUD 75.2 mn.
Us Masters Residential Prope (URF.AX) traded down -2.22 % and now trades at AUD 0.11. Current market capitalisation for Us Masters Residential Prope is AUD 75.7 mn.
Klevo (KLV.AX) traded down -1.96 % and now trades at AUD 0.48. Klevo has a market capitalisation of AUD 77.3 mn.
Spc Global (SPG.AX) traded flat 0 % and now trades at AUD 0.06. Spc Global has a market capitalisation of AUD 75.2 mn.
Diatreme (DRX.AX) traded down -3.23 % and now trades at AUD 0.01. Current market capitalisation for Diatreme is AUD 75.1 mn.
About Neurizon Therapeutics
PharmAust Limited is a clinical-stage biotechnology company based in Bentley, Australia. The company specializes in developing therapeutics for both human and animal health applications. In particular, they focus on repurposing monepantel (MPL) for human neurodegenerative diseases and treating cancer in dogs. You can find more information about this company and their activities on their website, www.pharmaust.com , and they are listed on the ASX All Markets stock exchange.